Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

By Cramer Joyce A.   Amonkar Mayur M.   Hebborn Ansgar   Altman Roy  

Current Medical Research and Opinion, Vol. 21, Iss. 9, 2005-09 ,pp. : 1453-1460

Informa Healthcare

Access to resources Recommend Favorite

Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis

By Penning-van Beest Fernie J. A.   Erkens Joëlle A.   Olson M.   Herings Ron M. C.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1337-1344

Informa Healthcare

Access to resources Recommend Favorite

Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™

By Barrett-Connor E.  

Osteoporosis International, Vol. 23, Iss. 2, 2012-02 ,pp. : 733-741

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates

By Earnshaw S. R.   Graham C. N.   Ettinger B.   Amonkar M. M.   Lynch N. O.   Middelhoven H.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2517-2529

Informa Healthcare

Access to resources Recommend Favorite

A systematic review of persistence and compliance with bisphosphonates for osteoporosis

By Cramer J.   Gold D.   Silverman S.   Lewiecki E.  

Osteoporosis International, Vol. 18, Iss. 8, 2007-08 ,pp. : 1023-1031

Springer Publishing Company

Access to resources Recommend Favorite